Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Artificial Lens Market Research Report 2019-2025

Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Artificial Lens Industry
  • 1.7 COVID-19 Impact: Artificial Lens Market Trends
  • 2 Global Artificial Lens Quarterly Market Size Analysis

    • 2.1 Artificial Lens Business Impact Assessment - COVID-19
      • 2.1.1 Global Artificial Lens Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
      • 2.1.2 Global Artificial Lens Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Artificial Lens Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 Global Artificial Lens Quarterly Market Size by Manufacturers, 2019 VS 2020
    • 3.2 Global Artificial Lens Factory Price by Manufacturers
    • 3.3 Location of Key Manufacturers Artificial Lens Manufacturing Factories and Area Served
    • 3.4 Date of Key Manufacturers Enter into Artificial Lens Market
    • 3.5 Key Manufacturers Artificial Lens Product Offered
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Artificial Lens Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Monofocal Artificial Lens
      • 1.4.2 Multifocal Artificial Lens
      • 1.4.3 Toric Artificial Lens
      • 1.4.4 Accommodative Artificial Lens
      • 1.4.5 Others
    • 4.2 By Type, Global Artificial Lens Market Size, 2019-2021
      • 4.2.1 By Type, Global Artificial Lens Market Size by Type, 2020-2021
      • 4.2.2 By Type, Global Artificial Lens Price, 2020-2021

    5 Impact of Covid-19 on Artificial Lens Segments, By Application

    • 5.1 Overview
      • 5.5.1 Hospitals
      • 5.5.2 Ophthalmology Clinics
      • 5.5.3 Ambulatory Surgery Centers
      • 5.5.4 Eye Research Institutes
    • 5.2 By Application, Global Artificial Lens Market Size, 2019-2021
      • 5.2.1 By Application, Global Artificial Lens Market Size by Application, 2019-2021
      • 5.2.2 By Application, Global Artificial Lens Price, 2020-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 ALCON
      • 7.1.1 ALCON Business Overview
      • 7.1.2 ALCON Artificial Lens Quarterly Production and Revenue, 2020
      • 7.1.3 ALCON Artificial Lens Product Introduction
      • 7.1.4 ALCON Response to COVID-19 and Related Developments
    • 7.2 AMO (Abbott)
      • 7.2.1 AMO (Abbott) Business Overview
      • 7.2.2 AMO (Abbott) Artificial Lens Quarterly Production and Revenue, 2020
      • 7.2.3 AMO (Abbott) Artificial Lens Product Introduction
      • 7.2.4 AMO (Abbott) Response to COVID-19 and Related Developments
    • 7.3 Bausch + Lomb
      • 7.3.1 Bausch + Lomb Business Overview
      • 7.3.2 Bausch + Lomb Artificial Lens Quarterly Production and Revenue, 2020
      • 7.3.3 Bausch + Lomb Artificial Lens Product Introduction
      • 7.3.4 Bausch + Lomb Response to COVID-19 and Related Developments
    • 7.4 HOYA
      • 7.4.1 HOYA Business Overview
      • 7.4.2 HOYA Artificial Lens Quarterly Production and Revenue, 2020
      • 7.4.3 HOYA Artificial Lens Product Introduction
      • 7.4.4 HOYA Response to COVID-19 and Related Developments
    • 7.5 CARL Zeiss
      • 7.5.1 CARL Zeiss Business Overview
      • 7.5.2 CARL Zeiss Artificial Lens Quarterly Production and Revenue, 2020
      • 7.5.3 CARL Zeiss Artificial Lens Product Introduction
      • 7.5.4 CARL Zeiss Response to COVID-19 and Related Developments
    • 7.6 Ophtec
      • 7.6.1 Ophtec Business Overview
      • 7.6.2 Ophtec Artificial Lens Quarterly Production and Revenue, 2020
      • 7.6.3 Ophtec Artificial Lens Product Introduction
      • 7.6.4 Ophtec Response to COVID-19 and Related Developments
    • 7.7 Rayner
      • 7.7.1 Rayner Business Overview
      • 7.7.2 Rayner Artificial Lens Quarterly Production and Revenue, 2020
      • 7.7.3 Rayner Artificial Lens Product Introduction
      • 7.7.4 Rayner Response to COVID-19 and Related Developments
    • 7.8 STAAR
      • 7.8.1 STAAR Business Overview
      • 7.8.2 STAAR Artificial Lens Quarterly Production and Revenue, 2020
      • 7.8.3 STAAR Artificial Lens Product Introduction
      • 7.8.4 STAAR Response to COVID-19 and Related Developments
    • 7.9 Lenstec
      • 7.9.1 Lenstec Business Overview
      • 7.9.2 Lenstec Artificial Lens Quarterly Production and Revenue, 2020
      • 7.9.3 Lenstec Artificial Lens Product Introduction
      • 7.9.4 Lenstec Response to COVID-19 and Related Developments
    • 7.10 HumanOptics
      • 7.10.1 HumanOptics Business Overview
      • 7.10.2 HumanOptics Artificial Lens Quarterly Production and Revenue, 2020
      • 7.10.3 HumanOptics Artificial Lens Product Introduction
      • 7.10.4 HumanOptics Response to COVID-19 and Related Developments
    • 7.11 Biotech Visioncare
      • 7.11.1 Biotech Visioncare Business Overview
      • 7.11.2 Biotech Visioncare Artificial Lens Quarterly Production and Revenue, 2020
      • 7.11.3 Biotech Visioncare Artificial Lens Product Introduction
      • 7.11.4 Biotech Visioncare Response to COVID-19 and Related Developments
    • 7.12 Omni Lens Pvt Ltd
      • 7.12.1 Omni Lens Pvt Ltd Business Overview
      • 7.12.2 Omni Lens Pvt Ltd Artificial Lens Quarterly Production and Revenue, 2020
      • 7.12.3 Omni Lens Pvt Ltd Artificial Lens Product Introduction
      • 7.12.4 Omni Lens Pvt Ltd Response to COVID-19 and Related Developments
    • 7.13 Aurolab
      • 7.13.1 Aurolab Business Overview
      • 7.13.2 Aurolab Artificial Lens Quarterly Production and Revenue, 2020
      • 7.13.3 Aurolab Artificial Lens Product Introduction
      • 7.13.4 Aurolab Response to COVID-19 and Related Developments
    • 7.14 SAV-IOL
      • 7.14.1 SAV-IOL Business Overview
      • 7.14.2 SAV-IOL Artificial Lens Quarterly Production and Revenue, 2020
      • 7.14.3 SAV-IOL Artificial Lens Product Introduction
      • 7.14.4 SAV-IOL Response to COVID-19 and Related Developments
    • 7.15 Eagle Optics
      • 7.15.1 Eagle Optics Business Overview
      • 7.15.2 Eagle Optics Artificial Lens Quarterly Production and Revenue, 2020
      • 7.15.3 Eagle Optics Artificial Lens Product Introduction
      • 7.15.4 Eagle Optics Response to COVID-19 and Related Developments
    • 7.16 SIFI Medtech
      • 7.16.1 SIFI Medtech Business Overview
      • 7.16.2 SIFI Medtech Artificial Lens Quarterly Production and Revenue, 2020
      • 7.16.3 SIFI Medtech Artificial Lens Product Introduction
      • 7.16.4 SIFI Medtech Response to COVID-19 and Related Developments
    • 7.17 Physiol
      • 7.17.1 Physiol Business Overview
      • 7.17.2 Physiol Artificial Lens Quarterly Production and Revenue, 2020
      • 7.17.3 Physiol Artificial Lens Product Introduction
      • 7.17.4 Physiol Response to COVID-19 and Related Developments

    8 Supply Chain and Sales Channels Analysis

    • 8.1 Artificial Lens Supply Chain Analysis
      • 8.1.1 Artificial Lens Supply Chain Analysis
      • 8.1.2 Covid-19 Impact on Artificial Lens Supply Chain
    • 8.2 Distribution Channels Analysis
      • 8.2.1 Artificial Lens Distribution Channels
      • 8.2.2 Covid-19 Impact on Artificial Lens Distribution Channels
      • 8.2.3 Artificial Lens Distributors
    • 8.3 Artificial Lens Customers

    9 Key Findings

      10 Appendix

      • 10.1 About Us

      This report covers market size and forecasts of Artificial Lens, including the following market information:
      Global Artificial Lens Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Artificial Lens Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Artificial Lens Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Artificial Lens Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)

      Key market players
      Major competitors identified in this market include ALCON, AMO (Abbott), Bausch + Lomb, HOYA, CARL Zeiss, Ophtec, Rayner, STAAR, Lenstec, HumanOptics, Biotech Visioncare, Omni Lens Pvt Ltd, Aurolab, SAV-IOL, Eagle Optics, SIFI Medtech, Physiol, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Monofocal Artificial Lens
      Multifocal Artificial Lens
      Toric Artificial Lens
      Accommodative Artificial Lens
      Others

      Based on the Application:
      Hospitals
      Ophthalmology Clinics
      Ambulatory Surgery Centers
      Eye Research Institutes

      Buy now